1. A pharmacokinetic, pharmacodynamic, and electrocardiographic study of liposomal mifamurtide (L-MTP-PE) in healthy adult volunteers

   • Karthik Venkatakrishnan
   • William G. Kramer
   • Cristina Oliva

   Clinical Trial 30 March 2012 Pages: 1347 - 1355

   

2. Absorption of different oral dosage forms of oxycodone in the elderly: a cross-over clinical trial in patients undergoing cystoscopy

   • Merja Kokki
   • Pyry Välitalo
   • Hannu Kokki

   Clinical Trial 27 March 2012 Pages: 1357 - 1363

   

3. Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD)

   • Maher R. Khdour
   • Ahmed F. Hawwa
   • James C. McElnay

   Clinical Trial 05 April 2012 Pages: 1365 - 1373

   

4. Salbutamol but not ipratropium abolishes leukotriene D₄-induced gas exchange abnormalities in asthma

   • Barbro Dahlén
   • Federico P Gómez
   • Robert Rodriguez-Roisin

   Pharmacodynamics 29 March 2012 Pages: 1375 - 1383

   

5. Pharmacokinetics, pharmacodynamics, and safety of clevidipine after prolonged continuous infusion in subjects with mild to moderate essential hypertension

   • William B. Smith
   • Thomas C. Marbury
   • Diane R. Mould

   Pharmacodynamics Open access 29 March 2012 Pages: 1385 - 1394

   

6. Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients

   • Xiao-Man Chu
   • Li-Fang Zhang
   • Hai-Ping Hao

   Pharmacogenetics 05 April 2012 Pages: 1395 - 1401

7. Pharmacokinetics of fondaparinux 1.5 mg once daily in a real-world cohort of patients with renal impairment undergoing major orthopaedic surgery

   • Xavier Delavenne
   • Paul Zufferey
   • for The PROPICE Study Group

   Pharmacokinetics and Disposition 25 March 2012 Pages: 1403 - 1410

   

8. Impact of cachexia on pharmacokinetic disposition of and clinical responses to oxycodone in cancer patients

   • Takafumi Naito
   • Masaki Tashiro
   • Junichi Kawakami

   Pharmacokinetics and Disposition 23 March 2012 Pages: 1411 - 1418

   

9. Abscess penetration of cefpirome: concentrations and simulated pharmacokinetic profiles in pus

   • Robert Sauermann
   • Thomas Feurstein
   • Markus Zeitlinger

   Pharmacokinetics and Disposition 23 March 2012 Pages: 1419 - 1423

   

10. Potentially inappropriate prescribing and cost outcomes for older people: a cross-sectional study using the Northern Ireland Enhanced Prescribing Database

    • Marie C. Bradley
    • Tom Fahey
    • Carmel M. Hughes

    Pharmacoepidemiology and Prescription 25 March 2012 Pages: 1425 - 1433

    

11. Choice of initial antihypertensive drugs and persistence of drug use—a 4-year follow-up of 78,453 incident users

    • Randi Selmer
    • Hege Salvesen Blix
    • Åsmund Reikvam

    Pharmacoepidemiology and Prescription 18 March 2012 Pages: 1435 - 1442

    

12. The use of medication against attention deficit hyperactivity disorder in Denmark: a drug use study from a national perspective

    • Anton Pottegård
    • Bine Kjøller Bjerregaard
    • Søren Ilsøe Moreno

    Pharmacoepidemiology and Prescription 21 March 2012 Pages: 1443 - 1450

    

13. Association of long-term adherence to evidence-based combination drug therapy after acute myocardial infarction with all-cause mortality. A prospective cohort study based on claims data

    • Jutta Kuepper-Nybelen
    • Martin Hellmich
    • Ingrid Schubert

    Pharmacoepidemiology and Prescription 04 April 2012 Pages: 1451 - 1460

    

14. Spontaneous ejaculation with the use of noradrenergic reuptake inhibitors

    • Ingrid Oosterhuis
    • Léon Heijting
    • Eugène van Puijenbroek

    Letter to the Editors 23 March 2012 Pages: 1461 - 1462

15. Linkage disequilibrium between the CYP2C19*17 allele and other clinically important CYP2C allelic variants in a healthy Scandinavian population

    • Rasmus Steen Pedersen
    • Mette Marie Hougaard Christensen
    • Kim Brøsen

    Letter to the Editors 04 April 2012 Pages: 1463 - 1464